SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (7603)5/1/1998 10:22:00 AM
From: 777 Captain  Respond to of 23519
 
Any chance you can be more specific - would appreciate any input. Regards.



To: Bradpalm1 who wrote (7603)5/1/1998 10:57:00 AM
From: RT  Read Replies (1) | Respond to of 23519
 
Brad,

So what's the BAD NEWS?
We can take it, good or bad.

Hardened Investor,
RT



To: Bradpalm1 who wrote (7603)5/1/1998 6:41:00 PM
From: Edderd  Read Replies (2) | Respond to of 23519
 
B You are exaggerating with the fireworks analogy. There is a balance and you have to read the abstracts. At home MUSE looks stronger every day . Noone will reach Viagra (maybe never) because of all the hype but its a big room to fill. Ed



To: Bradpalm1 who wrote (7603)5/5/1998 5:54:00 PM
From: DaiS  Respond to of 23519
 
Bradpalm1,

I have small addition to fireworks debate initiated by you.

For those physicians seeking publications for promotion, any and as many kinds of studies small, large, elegant, indifferent might do - who cares so long as its publishable.

Great to make a reputation as the scientific authority slagging off muse (or caverject or viagra .....).

Yes, lets wait to see the avalanche of viagra side-effect studies in a year or so. Look what happened today .... apparently.

DaiS



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News